ACEI

Objective: To observe the effects of the high dosage of Astragalus Injection united with the Angiotensin Converting Enzyme Inhibitor ( ACEI) on patients with nephrogenous albuminuria.

目的：观察大剂量黄芪联合血管紧张素转换酶抑制剂（ACEI）治疗肾性蛋白尿的疗效。

Conclusion: Ang ⅱ may play an important role in the pathogenesis of DED, and the Ang ⅱ antagonist or inhibitor of the angiotensin-converting enzyme ( ACEI) may become a therapeutic method for DED in the future.

结论AngⅡ在DED大鼠血浆及海绵体组织中显著升高，在DED的发病中可能具有重要作用，血管紧张素转化酶抑制剂（ACEI）或AngⅡ受体拮抗剂有望成为治疗DED的重要方法之一。

Objective To investigate the efficacy and satety of large-dose ACEI and ARB on diabetic nephritic syndrome.

目的观察大剂量转换酶抑制剂（ACEI）及受体拮抗剂（ARB）联合治疗糖尿病肾病综合征的疗效并评价其安全性。

RESULTS: The sales volume of calcium channel blocker in Hangzhou has accounted for 53.04%, ACEI accounted for about 16.36% and angiotensin n acceptor antagonistic drug accounted for about 19.08% of the total consumption.

结果：杭州地区的钙通道拮抗剂的用药金额约占抗高血压药总金额的53.04%，血管紧张素转换酶抑制药约占16.36%，血管紧张素II受体拮抗药约占19.08%。

Objective To evaluate the clinical therapeutic effect of the Tab Glycyrrhiza Compound on Angiotensin-converting Enzyme Inhibitors ( ACEI) cough.

目的评价复方甘草片对血管紧张素转换酶抑制剂（ACEI）性咳嗽的临床疗效。

In vitro, ACEI retarded the growth of cultured cancer cells, inhibited the growth and angiogenesis of several tumors in various animal models.

体外实验发现ACEI能够延缓肿瘤细胞的生长，对不同的动物模型显示出抑制肿瘤生长和血管生成作用。

If necessary, reduce ACEI dose or discontinue.

必要时可减少ACEI剂量或中止使用.

The incidence of ACEI related adverse reactions, such as rapid increase of Scr more than 30%, dry cough or hyperkalemia were not different among the three groups.

Ⅰ组患者治疗后2个月内Scr增加超过30%的人数及咳嗽、高血钾等副作用的发生率与A组、Ⅱ组相比无明显增加。

Is combined ACEI and ARB necessary for treatment of hypertension?

高血压药物治疗:ACEI与 arb的合用是否必需?

Objective To investigate the effect of angiotensin II type I receptor blocker ( AR1B) and angiotensin converting anzyme inhibitor ( ACEI) on deposition of collagen in infarct zone ( IZ) and non-infarct zone ( NIZ) in myocardial infarction ( MI) rabbits.

目的研究选择性血管紧张素Ⅱ受体1拮抗剂（AR1B）、血管紧张素转化酶抑制剂（ACEI）对心肌梗死（MI）后心肌胶原重构的影响。

Objective To evaluate the pharmaceutical effect of angiotensin-converting enzyme inhibitor ( ACEI ) captopril on ischemic myocardium.

目的评价血管紧张素转换酶抑制剂 ( ACEI ) 卡托普利对缺血心肌的药理作用.

CONCLUSION RAA has principal place in the improvement on renal fuction of ACEI, but KK or PGs do not play an important role in it.

结论RAA在ACEI改善肾脏功能作用中起主要作用，而K-K及PGs不起重要作用。

ACEI& a cornerstone in the management of chronic congestive heart failure therapy

ACEI&慢性充血性心力衰竭治疗的基石

Results ACEI caused the damage of salt taste and bitter taste Zinc sulfate could treat it.

结果肾素血管紧张素主要导致咸味和苦味损伤,硫酸锌对此有治疗作用.

ACEI improves ventricular function and patient well-being, reduces hospital admission for worsening HF, and increases survival.

它可以改善心室功能,病人预后, 减少心衰恶化再次住院, 提高存活率.

RESULTS& CONCLUSION: By statistics, based on the classification of the function of antihypertension drugs, it is found that in the clinic the patients with hypertension use ACEI most frequently in Beijing, Tianjin and Guangzhou.

结果与结论：通过统计，抗高血压药物按其作用分类情况看，在临床中，高血压患者使用血管紧张素转换酶抑制剂（ACEI）类型降压药，居于北京、天津、广州地区首位。

Combined use of ACEI and ARB has stronger effect than big dose of single drug.

ACEI和ARB联合 应用比单个药物大剂量应用有更强的降尿蛋白作用.

The research of nephroprotection and cost effectiveness about ACEI in chronic nephropathies

ACEI在慢性肾病中肾保护作用及费用效益关系的研究进展

DTI can be a new method for assessment of therapeutic effect.

结论ACEI能 改善高血压患者腹主动脉壁的弹性,DTI技术 是一种用于评价该药物疗效的新方法.